Valuation: Crossject

Market Cap 85.8M 97.89M 79.5M 73.18M 138M 9.43B 140M 949M 371M 4.62B 367M 360M 15.95B P/E 2026 *
3.84x
P/E 2027 * 3.03x
Enterprise Value 67.9M 77.47M 62.92M 57.91M 109M 7.46B 111M 751M 294M 3.66B 291M 285M 12.63B EV / Sales 2026 *
1.12x
EV / Sales 2027 * 0.92x
Free-Float
90.34%
Yield 2026 *
-
Yield 2027 * -
1 day-1.02%
1 week-3.35%
Current month-12.56%
1 month-16.84%
3 months-22.00%
6 months-22.77%
Current year-28.77%
1 week 1.54
Extreme 1.536
1.67
1 month 1.54
Extreme 1.536
1.92
Current year 1.54
Extreme 1.536
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.36
Manager TitleAgeSince
Chief Executive Officer 63 2001-08-07
Director of Finance/CFO - 2026-03-24
Corporate Officer/Principal - 2024-08-19
Director TitleAgeSince
Chairman 67 2009-06-25
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
7/4/25 Buy

Director

13,386 0.0266%
7/1/25 Buy

Director

1,132 0.0022%
7/1/25 Buy

Director

337 0.0007%
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-3.35%-2.86%-58.06% 97.89M
-0.92%-1.81%-40.68%-65.47% 89.57M
-0.27%-2.51%+58.37%-1.07% 70.54M
Average -0.74%-1.47%+4.94%-41.54% 86M
Weighted average by Cap. -0.78%-1.52%+0.75%-45.05%

Financials

2026 *2027 *
Net sales 60.8M 69.37M 56.34M 51.85M 97.78M 6.68B 98.96M 672M 263M 3.27B 260M 255M 11.3B 42.3M 48.26M 39.19M 36.07M 68.02M 4.65B 68.85M 468M 183M 2.28B 181M 177M 7.86B
Net income 28.3M 32.29M 26.22M 24.13M 45.51M 3.11B 46.06M 313M 122M 1.52B 121M 119M 5.26B 7.75M 8.84M 7.18M 6.61M 12.46M 852M 12.61M 85.7M 33.54M 417M 33.19M 32.48M 1.44B
Net Debt -17.9M -20.42M -16.59M -15.27M -28.79M -1.97B -29.13M -198M -77.46M -964M -76.66M -75.01M -3.33B -47M -53.62M -43.55M -40.08M -75.58M -5.16B -76.5M -520M -203M -2.53B -201M -197M -8.74B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
26-07-22 1.560 -1.02% 34,270
26-07-21 €1.576 -0.38% 298,495
26-07-20 €1.582 -2.94% 103,587
26-07-17 €1.630 -1.69% 96,320
26-07-16 €1.658 +2.73% 58,190
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.576EUR
Average target price
4.400EUR
Spread / Average Target
+179.19%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock